The Growing Evidence for PRP in Chronic Plantar Fasciitis

Chronic plantar fasciitis remains one of the most common causes of heel pain. While many patients respond to conservative treatments such as stretching, orthotics, activity modification, physical therapy, and anti-inflammatory medications, a subset continues to experience persistent symptoms that significantly affect function and quality of life.

As understanding of chronic plantar fasciitis has evolved, attention has shifted from viewing the condition as purely inflammatory to recognizing the role of degenerative changes within the plantar fascia. This perspective has contributed to growing interest in regenerative medicine approaches, including platelet-rich plasma, as potential treatment options for chronic cases.

Why Are Regenerative Approaches Gaining Attention?

Platelet-rich plasma is an autologous biologic preparation created by concentrating platelets and growth factors from a patient’s own blood. Once injected into the affected tissue, PRP is thought to support the body’s natural healing processes by promoting tissue repair and modulating the local biological environment.

Unlike corticosteroid injections, which primarily target inflammation and may provide rapid symptom relief, PRP aims to address the underlying degenerative changes associated with chronic plantar fasciitis.

Because of its favorable safety profile and regenerative potential, PRP has become an area of increasing interest within podiatry and sports medicine.

What Does the Latest Evidence Tell Us?

A recent systematic review and meta-analysis titled “Platelet rich plasma therapy versus other modalities for treatment of plantar fasciitis” evaluated the role of platelet-rich plasma in the treatment of plantar fasciitis, analyzing data from 21 randomized controlled trials involving 1,356 patients.

The study compared PRP with several commonly used treatment modalities, including corticosteroid injections (CSI), extracorporeal shock wave therapy (ESWT), placebo, dextrose prolotherapy, phonophoresis, and meridian trigger point therapy.

Key findings included:

• PRP demonstrated significantly greater reductions in pain scores compared with corticosteroid injections, ESWT, and placebo.
• Functional outcomes, measured by the American Orthopaedic Foot & Ankle Society (AOFAS) score, were significantly improved with PRP compared with corticosteroid injections and placebo.
• While PRP did not consistently outperform every comparator across all functional outcome measures, it showed substantial benefits over phonophoresis and comparable results to several other established therapies.
• The authors concluded that PRP offers meaningful clinical advantages for pain reduction while highlighting the need for greater standardization in PRP preparation protocols and outcome reporting.

Rather than suggesting a single treatment strategy for all patients, these findings support PRP as an evidence-based option within the broader treatment algorithm for chronic plantar fasciitis.

PRP Versus Corticosteroid Injections

Corticosteroid injections have long been used to manage plantar fasciitis because of their ability to provide relatively rapid symptom relief. However, growing evidence suggests that PRP may offer distinct advantages for long-term management.

The recent meta-analysis found that PRP was associated with:

• Greater reductions in pain compared with corticosteroid injections.
• Superior improvements in AOFAS functional scores.
• Sustained clinical benefits that may extend beyond the short-term effects commonly associated with corticosteroids.

At the same time, the authors noted that PRP did not demonstrate superiority across every reported functional outcome measure, emphasizing that treatment decisions should consider individual patient factors, physician preference, and clinical objectives.

For foot and ankle specialists managing chronic plantar fasciitis, PRP may represent a valuable regenerative option, particularly for patients who have not achieved adequate improvement with conservative therapies and are seeking alternatives to repeated corticosteroid injections.

What Does This Mean for Foot and Ankle Specialists?

The growing body of evidence supports the consideration of PRP as part of a comprehensive treatment strategy for chronic plantar fasciitis, particularly in patients who:

• Have experienced symptoms for several months.
• Have not responded to conservative management.
• Seek minimally invasive treatment options.
• May benefit from regenerative approaches before considering surgical intervention.

As with any biologic therapy, patient selection, preparation protocols, injection technique, and post-procedure rehabilitation remain important considerations for optimizing outcomes.

Current literature supports an evidence-based approach to incorporating PRP into clinical practice while recognizing that ongoing research will continue to refine indications and best practices.

Tropocells® PRP: Supporting Office-Based PRP Procedures

The Tropocells® PRP System utilizes patented separator gel technology designed to isolate and concentrate platelets while reducing undesirable blood components, including red blood cells and neutrophils, which are associated with inflammatory responses. At the same time, the system preserves monocytes and lymphocytes, supporting a balanced PRP formulation for musculoskeletal applications.

Key features include:

• Patented separator gel technology for efficient separation
• Selective leukocyte profile, with ~86% of WBCs in the PRP fraction being monocytes
• Rapid processing time (less than 15 minutes from draw to injection)
• Sterile, closed system designed to support procedural consistency
• Specially treated tubes to help minimize platelet adhesion and cell lysis

As evidence for PRP continues to expand in conditions such as chronic plantar fasciitis, office-based preparation systems like Tropocells® may help physicians incorporate regenerative therapies into their practice with an efficient and streamlined approach.

Frequently Asked Questions

Q1: What is chronic plantar fasciitis?

Chronic plantar fasciitis is a degenerative condition of the plantar fascia characterized by persistent heel pain lasting several months and often resistant to conservative treatment.

Q2: When should PRP be considered for plantar fasciitis?

PRP may be considered for patients with chronic plantar fasciitis who have not achieved adequate improvement with stretching, orthotics, physical therapy, activity modification, or other conservative measures.

Q3: What does the latest evidence say about PRP for plantar fasciitis?

A 2024 systematic review and meta-analysis of 21 randomized controlled trials involving 1,356 patients found that PRP provided superior long-term pain reduction compared with corticosteroid injections.

Q4: What outcomes have been reported with PRP?

Studies have reported reductions in pain, improvements in functional outcomes, and sustained clinical benefits in patients with chronic plantar fasciitis.

Q5: What should physicians consider when incorporating PRP into their practice?

Important considerations include patient selection, PRP preparation protocols, injection technique, ultrasound guidance, rehabilitation strategies, and clinical workflow integration.

Q6: What PRP preparation options are available?

Several regenerative medicine preparation systems are available for office-based use. Epimed’s Tropocells® PRP is designed to support efficient preparation of autologous platelet-rich plasma for regenerative medicine applications.